Behavioral and Immunohistological Assessment of Painful Neuropathy Induced by a Single Oxaliplatin Injection in the Rat

Bing Ling,Marie-Ange Coudore-Civiale,David Balayssac,Alain Eschalier,Francois Coudore,Nicolas Authier

DOI: https://doi.org/10.1016/j.tox.2007.02.013

IF: 4.571

2007-01-01

Toxicology

Abstract:In clinical use, a single infusion of oxaliplatin, widely used to treat metastatic colorectal cancer, induces specific sensory neurotoxicity signs triggered or aggravated by exposure to cold. To study the pathophysiology of these symptoms, we developed and characterized an animal model that reproduces the effects of a single intraperitoneal oxaliplatin administration (3, 6 and 12mg/kg). Significant allodynia and hyperalgesia to cold stimuli were rapidly observed from 24h to day 5 with a maximum lowering of 76% at t+30h versus control. Other behavioral assessments revealed rapid persistent mechanical allodynia, but no thermal hyperalgesia or allodynia to heat and no hyperalgesia to mechanical stimuli. An immunohistochemical study in the superficial layers of the spinal dorsal horn revealed a marked increase in substance P immunoreactivity versus controls (12% versus 4%), whereas calcitonin gene-related peptide (CGRP) immunoreactivity was unchanged. This new animal model for the first time closely mimics the effects observed in humans after a single oxaliplatin infusion, especially onset and highly intense sensory disturbances, hypersensitivity to cold with allodynia and hyperalgesia signs. This model may help to elucidate the mechanisms of this thermal hypersensitivity, especially the possible involvement of small-diameter A-fibers in cold allodynia symptoms. These selective effects may clue up the mechanistic basis for the acute oxaliplatin neuropathy leading to a better understanding of the clinical condition and to optimize its treatment.